Clinical Effect of the Warburg Effect in Stage IV Hepatocellular Carcinoma
Preprint
- 12 May 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The Warburg effect is a metabolic phenomenon observed in cancer cells and is characterized by aerobic glycolysis instead of mitochondrial oxidative phosphorylation as the primary mechanism of cellular energy generation. The exact benefit of such a metabolic switch is poorly understood, as aerobic glycolysis is thermodynamically more inefficient than mitochondrial oxidative phosphorylation. Here, we present a case of a 40-year-old male with advanced stage 4 hepatocellular carcinoma with chronically low glucose levels measured in the 20s to 40s and completely asymptomatic. Upon examination, findings of sympathetic hyperactivity in the setting of hypoglycemia were absent, and mentation was completely intact. This occurred in the absence of any states or medications known to induce hypoglycemia; concurrently, the patient demonstrated hyperphagia, suggesting increased metabolic demand in the setting of an immense, overwhelming tumor burden. During these hypoglycemic intervals, the patient's coagulation profile, including PT and international normalized ratio, remained within normal limits, suggesting sufficient residual hepatic parenchyma and glucogenic capacity. The patient's glucose remained extremely low, refractory to correction with multiple dextrose, D5, and D10 administrations. This suggests chronic systemic habituation to malignant cell consumption of serum glucose leading to adaptations to this hypoglycemia in highly metabolically active organs, such as the brain, heart, liver, and kidneys. This report highlights the clinical utility of recognizing this metabolic state in the setting of advanced-stage malignancy with significant tumor burden and how it affects hospital glucose management. Its early recognition will lead to improvements in meeting the patient's metabolic demands while avoiding paradoxical exacerbation of lactic acidosis when providing guideline-directed oncological treatment. This metabolic state may function as a surrogate marker, in conjunction with serum markers and imaging studies, for clinical identification of advanced stage malignancies and for treatment escalation.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapiesClinical and Experimental Medicine, 2024
- Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implicationsJournal of Hematology & Oncology, 2022
- Tumor microenvironment components: Allies of cancer progressionPathology - Research and Practice, 2020
- ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibitionLeukemia, 2017
- Introduction to the molecular basis of cancer metabolism and the Warburg effectMolecular Biology Reports, 2015
- Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapyCancer and Metastasis Reviews, 2014
- L’effet Warburgmédecine/sciences, 2013
- Acidity Generated by the Tumor Microenvironment Drives Local InvasionCancer Research, 2013
- Lactate: A Preferred Fuel for Human Brain Metabolism in VivoJournal of Cerebral Blood Flow & Metabolism, 2003
- The Effect of Intravenous Lactate on Cerebral Function During HypoglycaemiaDiabetic Medicine, 1997